BioNTech sign deal to co-develop OncoC4’s cancer drug, Health News, ET HealthWorld
New Delhi: Germany's BioNTech SE mentioned on Monday that it signed a deal with privately held OncoC4 Inc to co-develop and commercialize its cancer antibody drug candidate.OncoC4 will get ...
